Valneva SE (VALN) Prepaid Assets (2021 - 2026)
Valneva SE's (VALN) quarterly Prepaid Assets came in at $41.5 million in Q1 2026, up 1.57% year-on-year from $40.9 million in Q1 2025, and up 2.34% quarter-over-quarter from $40.6 million in Q4 2025.
Valneva SE (VALN) Prepaid Assets (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Prepaid Assets across 6 years of filings, most recently posting $41.5 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $41.5 million, up 1.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $41.5 million (up 1.57% YoY), and the FY2025 annual result was $40.6 million, down 9.35% from the prior year.
- Prepaid Assets came in at $41.5 million for Q1 2026 at Valneva SE, up from $40.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $77.4 million in Q1 2022 to a low of $40.6 million in Q4 2025.
- The 5-year median for Prepaid Assets is $59.0 million (2022), against an average of $57.9 million.
- Across the five-year window, Prepaid Assets advanced 22.36% in 2023 and tumbled 32.35% in 2025, its largest moves.
- Valneva SE's Prepaid Assets stood at $75.6 million in 2022, then retreated by 27.92% to $54.5 million in 2023, then slipped by 17.86% to $44.7 million in 2024, then retreated by 9.35% to $40.6 million in 2025, then gained by 2.34% to $41.5 million in 2026.
- The last three Prepaid Assets figures came in at $41.5 million (Q1 2026), $40.6 million (Q4 2025), and $47.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.51 Mn |
| Dec 31, 2025 | 40.56 Mn |
| Sep 30, 2025 | 47.35 Mn |
| Jun 30, 2025 | 42.51 Mn |
| Mar 31, 2025 | 40.87 Mn |
| Dec 31, 2024 | 44.75 Mn |
| Sep 30, 2024 | 64.89 Mn |
| Jun 30, 2024 | 62.84 Mn |
| Mar 31, 2024 | 58.37 Mn |
| Dec 31, 2023 | 54.48 Mn |
| Sep 30, 2023 | 72.99 Mn |
| Jun 30, 2023 | 70.87 Mn |
| Mar 31, 2023 | 71.58 Mn |
| Dec 31, 2022 | 75.58 Mn |
| Sep 30, 2022 | 59.65 Mn |
| Mar 31, 2022 | 77.41 Mn |
| Dec 31, 2021 | 81.26 Mn |